Literature DB >> 32073233

On the Binding of Congo Red to Amyloid Fibrils.

Alba Espargaró1,2, Salomé Llabrés3, Sven J Saupe4, Carles Curutchet1,5, F Javier Luque5,6,7, Raimon Sabaté1,2.   

Abstract

Amyloids are characterized by their capacity to bind Congo red (CR), one of the most used amyloid-specific dyes. The structural features of CR binding were unknown for years, mainly because of the lack of amyloid structures solved at high resolution. In the last few years, solid-state NMR spectroscopy enabled the determination of the structural features of amyloids, such as the HET-s prion forming domain (HET-s PFD), which also has recently been used to determine the amyloid-CR interface at atomic resolution. Herein, we combine spectroscopic data with molecular docking, molecular dynamics, and excitonic quantum/molecular mechanics calculations to examine and rationalize CR binding to amyloids. In contrast to a previous assumption on the binding mode, our results suggest that CR binding to the HET-s PFD involves a cooperative process entailing the formation of a complex with 1:1 stoichiometry. This provides a molecular basis to explain the bathochromic shift in the maximal absorbance wavelength when CR is bound to amyloids.
© 2020 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Congo red; amyloids; fibrous proteins; prions; proteins

Mesh:

Substances:

Year:  2020        PMID: 32073233     DOI: 10.1002/anie.201916630

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  4 in total

1.  A fluorogenic probe for granzyme B enables in-biopsy evaluation and screening of response to anticancer immunotherapies.

Authors:  Jamie I Scott; Lorena Mendive-Tapia; Doireann Gordon; Nicole D Barth; Emily J Thompson; Zhiming Cheng; David Taggart; Takanori Kitamura; Alberto Bravo-Blas; Edward W Roberts; Jordi Juarez-Jimenez; Julien Michel; Berber Piet; I Jolanda de Vries; Martijn Verdoes; John Dawson; Neil O Carragher; Richard A O' Connor; Ahsan R Akram; Margaret Frame; Alan Serrels; Marc Vendrell
Journal:  Nat Commun       Date:  2022-05-02       Impact factor: 17.694

2.  Alzheimer's Disease "Non-amyloidogenic" p3 Peptide Revisited: A Case for Amyloid-α.

Authors:  Ariel J Kuhn; Benjamin S Abrams; Stella Knowlton; Jevgenij A Raskatov
Journal:  ACS Chem Neurosci       Date:  2020-05-22       Impact factor: 4.418

3.  Evaluation of Styrylbenzene analog- FSB and its affinity to bind parenchymal plaques and tangles in patients of Alzheimer's disease.

Authors:  Sharay E Setti; Nikita Das; James Raymick; Joseph Hanig; Sumit Sarkar
Journal:  Metab Brain Dis       Date:  2022-01-22       Impact factor: 3.584

4.  Neuroprotective Effects of a Novel Demeclocycline Derivative Lacking Antibiotic Activity: From a Hit to a Promising Lead Compound.

Authors:  Rodrigo Tomas-Grau; Florencia González-Lizárraga; Diego Ploper; César L Avila; Sergio B Socías; Pierre Besnault; Aurore Tourville; Rosa M Mella; Patricia Villacé; Clarisa Salado; Clémence Rose; Blandine Seon-Méniel; Jean-Michel Brunel; Laurent Ferrié; Rita Raisman-Vozari; Patrick P Michel; Bruno Figadère; Rosana Chehín
Journal:  Cells       Date:  2022-09-04       Impact factor: 7.666

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.